<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="185865-2018"
            EDITION="2018082">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-188755-001</RECEPTION_ID>
      <DELETION_DATE>20180607</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>82</NO_OJ>
         <DATE_PUB>20180427</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 082-185865</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:185865-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="NO"/>
         <IA_URL_GENERAL>https://permalink.mercell.com/84609763.aspx</IA_URL_GENERAL>
         <IA_URL_ETENDERING>https://permalink.mercell.com/84609763.aspx</IA_URL_ETENDERING>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="NO01">Oslo og Akershus</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="NO01">Oslo og Akershus</n2016:CA_CE_NUTS>
         <VALUES>
            <VALUE TYPE="ESTIMATED_TOTAL" CURRENCY="NOK">230000000.00</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 195-401937</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180426</DS_DATE_DISPATCH>
         <DT_DATE_FOR_SUBMISSION>20180607 12:00</DT_DATE_FOR_SUBMISSION>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="3">Contract notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="B">European Economic Area (EEA), with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="1">Submission for all lots</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>03B02</HEADING>
         <INITIATOR>03</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Норвегия</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Norsko</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Norge</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Norwegen</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Νορβηγία</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Norway</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Noruega</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Norra</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Norja</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Norvège</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Iorua, an</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Norveška</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Norvégia</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Norvegia</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Norvegija</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Norvēģija</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>in-Norveġja</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Noorwegen</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Norwegia</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Noruega</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Norvegia</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Nórsko</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Norveška</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Norge</TI_CY>
            <TI_TOWN>Vadsø</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">Sykehusinnkjøp HF</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F02_2014 CATEGORY="ORIGINAL" FORM="F02" LG="EN">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Sykehusinnkjøp HF</OFFICIALNAME>
               <NATIONALID>916879067</NATIONALID>
               <ADDRESS>Postboks 40</ADDRESS>
               <TOWN>Vadsø</TOWN>
               <POSTAL_CODE>9811</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <CONTACT_POINT>Eirik Sverrisson</CONTACT_POINT>
               <E_MAIL>eirik.sverrisson@sykehusinnkjop.no</E_MAIL>
               <n2016:NUTS CODE="NO01"/>
               <URL_GENERAL>https://permalink.mercell.com/84609763.aspx</URL_GENERAL>
               <URL_BUYER>http://www.sykehusinnkjop.no/</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <CENTRAL_PURCHASING/>
            <DOCUMENT_FULL/>
            <URL_DOCUMENT>https://permalink.mercell.com/84609763.aspx</URL_DOCUMENT>
            <ADDRESS_FURTHER_INFO>
               <OFFICIALNAME>Mercell Norge AS</OFFICIALNAME>
               <ADDRESS>Karihaugveien 89</ADDRESS>
               <TOWN>Oslo</TOWN>
               <POSTAL_CODE>1086</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <E_MAIL>support@mercell.com</E_MAIL>
               <n2016:NUTS CODE="NO01"/>
               <URL_GENERAL>https://permalink.mercell.com/84609763.aspx</URL_GENERAL>
            </ADDRESS_FURTHER_INFO>
            <URL_PARTICIPATION>https://permalink.mercell.com/84609763.aspx</URL_PARTICIPATION>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>LIS 1813 LAR</P>
            </TITLE>
            <REFERENCE_NUMBER>2017/1223</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Open tender contest LIS LAR 1813. The competition is for medicines used for opioids dependency, ATC code N07B C, (see the list of active ingredients).</P>
               <P>Tender notice on behalf of Helse Nord RHF, Helse Midt-Norge RHF, Helse Sør-Øst RHF and [Northern Norway Regional Health Authority, Central Norway Regional Health Authority, South Eastern Norway Regional Health Authority and].</P>
               <P>Helse Vest RHF [Western Norway Regional Health Authority],</P>
            </SHORT_DESCR>
            <VAL_ESTIMATED_TOTAL CURRENCY="NOK">230000000.00</VAL_ESTIMATED_TOTAL>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <n2016:NUTS CODE="NO01"/>
               <SHORT_DESCR>
                  <P>The Contracting Authorities shall enter into framework agreements for special pharmaceutical preparations with the indication substitution treatment for opioid dependency, in accordance with the active ingredients list (annex 3). These medicines are used in medicine assisted rehabilitation, hereafter called LAR. The medicines in this document are called 'LAR medicines'.</P>
                  <P>The medicines can be used as replacements for each other in many indications. Doctors in the specialist health service will make decisions on what is included and taken out of LAR. The implementation / follow-up of treatment can be left to the primary health service, it shall occur in close cooperation with the specialist health service.</P>
                  <P>In the first part of the contract period, from 1.10.2018 to 31.1.2019, the total contract value is estimated to be a maximum of approx. 30 000 000 NOK, based on historical consumption (December 2016 — December 2017). From 1.2.2019 the total contract extent is estimated to be approx. 100 000 000 NOK per annum, based on historical consumption (November 2016 - November 2017). The contract shall cover the need at all times. Previous consumption in 2016/2017 is only a guidelines for the consumption in the pending contract period.</P>
                  <P>The reason for the division is an overlap between existing and current contracts. Contracts exist (LIS 1801 and LIS 1701b) for LAR medicines used in the specialist health service. These contracts are valid until 31.1.2019. Therefore, the contracts from this competition (LAR 1813) will apply for LAR medicines used outside the specialist health service from 1.10.2018 until 31.1.2019. From 1.2.2019, these contracts (LAR 1813) will also apply to LAR medicines used in the specialist health service.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <VAL_OBJECT CURRENCY="NOK">230000000.00</VAL_OBJECT>
               <DATE_START>2018-10-01</DATE_START>
               <DATE_END>2020-01-31</DATE_END>
               <RENEWAL/>
               <RENEWAL_DESCR>
                  <P>The framework agreement can be extended for four months at a time for a maximum of 12 months, with a maximum contract length of 28 months.</P>
               </RENEWAL_DESCR>
               <NO_ACCEPTED_VARIANTS/>
               <OPTIONS/>
               <OPTIONS_DESCR>
                  <P>The framework agreement can be extended for four months at a time for a maximum of 12 months, with a maximum contract length of 28 months.</P>
               </OPTIONS_DESCR>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <LEFTI>
            <TECHNICAL_CRITERIA_DOC/>
            <PERFORMANCE_CONDITIONS>
               <P>See the tender documentation and annexes.</P>
            </PERFORMANCE_CONDITIONS>
         </LEFTI>
         <PROCEDURE>
            <PT_OPEN/>
            <FRAMEWORK>
               <SEVERAL_OPERATORS/>
            </FRAMEWORK>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 195-401937</NOTICE_NUMBER_OJ>
            <DATE_RECEIPT_TENDERS>2018-06-07</DATE_RECEIPT_TENDERS>
            <TIME_RECEIPT_TENDERS>12:00</TIME_RECEIPT_TENDERS>
            <LANGUAGES>
               <LANGUAGE VALUE="DA"/>
               <LANGUAGE VALUE="NO"/>
               <LANGUAGE VALUE="SE"/>
            </LANGUAGES>
            <DATE_TENDER_VALID>2018-09-28</DATE_TENDER_VALID>
            <OPENING_CONDITION>
               <DATE_OPENING_TENDERS>2018-06-07</DATE_OPENING_TENDERS>
               <TIME_OPENING_TENDERS>12:00</TIME_OPENING_TENDERS>
            </OPENING_CONDITION>
         </PROCEDURE>
         <COMPLEMENTARY_INFO>
            <NO_RECURRENT_PROCUREMENT/>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Sykehusinnkjøp HF, divisjon legemidler</OFFICIALNAME>
               <ADDRESS>Grev Wedels plass 7</ADDRESS>
               <TOWN>Oslo</TOWN>
               <POSTAL_CODE>0151</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <E_MAIL>legemidler@sykehusinnkjop.no</E_MAIL>
               <URL>http://sykehusinnkjop.no</URL>
            </ADDRESS_REVIEW_BODY>
            <ADDRESS_MEDIATION_BODY>
               <OFFICIALNAME>Klagenemda for offentlige anskaffelser</OFFICIALNAME>
               <ADDRESS>Postboks 439 Sentrum</ADDRESS>
               <TOWN>Bergen</TOWN>
               <POSTAL_CODE>5805</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <PHONE>+47 55597500</PHONE>
               <E_MAIL>postmottak@kofa.no</E_MAIL>
               <FAX>+47 55597599</FAX>
               <URL>http://www.kofa.no</URL>
            </ADDRESS_MEDIATION_BODY>
            <ADDRESS_REVIEW_INFO>
               <OFFICIALNAME>Sykehusinnkjøp HF, divisjon legemidler</OFFICIALNAME>
               <ADDRESS>Grev Wedels plass 7</ADDRESS>
               <TOWN>Oslo</TOWN>
               <POSTAL_CODE>0151</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <E_MAIL>legemidler@sykehusinnkjop.no</E_MAIL>
               <URL>http://sykehusinnkjop.no</URL>
            </ADDRESS_REVIEW_INFO>
            <DATE_DISPATCH_NOTICE>2018-04-26</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F02_2014>
   </FORM_SECTION>
</TED_EXPORT>
